Off-resonance MRI Detection with Complementary Contrast Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current MRI techniques using super-paramagnetic iron-oxide nanoparticles as negative contrast agents face challenges in distinguishing labeled cells from image voids and suffer from partial-volume effects, limiting their effectiveness in visualization.
Innovation Solution
Employing a sequence of RF excitation near magnetically labeled cells to create a baseline off-resonance signal, followed by administration of a second contrast agent to detect its presence, utilizing at least two complementary contrast agents for enhanced visualization with improved background noise suppression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If negative contrast agents (SPIO particles) are used for cell labeling, then cell visualization is achieved through signal dephasing, but the labeled cells cannot be distinguished from image voids and suffer from partial-volume effects
Solution Approach 1:
The patent applies spectral frequency shifting to change the 'color' (frequency) of the signal from labeled cells. By applying a frequency shift to the reference signal, the off-resonance signal from labeled cells appears at a different frequency than background tissue, enabling clear distinction between labeled cells and image voids without ambiguity
Solution Approach 2:
The patent introduces a frequency dimension to differentiate labeled cells from background. Instead of relying solely on spatial information, the off-resonance signal is detected at a shifted frequency, adding a spectral dimension that resolves the ambiguity between true voids and labeled cells
2Reliability
If negative contrast agents are used, then signal voids are produced for detection, but detection reliability depends critically on image resolution with partial-volume effects
Solution Approach 1:
The patent changes the detection parameter from spatial intensity (which requires high resolution) to spectral frequency. By detecting the frequency-shifted off-resonance signal, the method becomes less sensitive to partial-volume effects and image resolution, improving detection reliability across different imaging conditions
3Measurement precision
If T1 weighting is used to achieve positive contrast with SPIOs, then positive contrast is obtained, but the method is inefficient due to competing T1 and T2* effects and is limited to smaller-sized particles
Solution Approach 1:
The patent extracts the T2* effect from the competing T1 and T2* mechanisms by using frequency-selective detection. Instead of relying on T1 weighting where both effects compete, the method selectively detects the off-resonance signal at a shifted frequency, isolating the T2*-induced frequency shift as the primary contrast mechanism and eliminating the inefficiency of competing effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables positive contrast imaging with reduced background noise, allowing for the detection of the second contrast agent's effects and providing temporal information on its interaction with tissues, enhancing the sensitivity and resolution of MRI imaging.
Implementation Method 1
Cells loaded with SPIO cause significant signal dephasing due to the magnetic field inhomogeneity induced in water molecules near the cell
Implementation Method 2
spectrally-selective RF pulses are used to excite and refocus the off-resonance water surrounding the cells labeled with SPIO agents
Data Source
AI summary
Off-resonance imaging uses two complementary contrast agents with the first agent (iron-oxide) particles transfected into cells which provide localized signals. The second agent is detected from a change in the off-resonance signal when present in the cells labeled by the first agent.